These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32232702)

  • 41. Salvage endoscopic resection after definitive chemoradiotherapy for esophageal cancer: a Western experience.
    Al-Kaabi A; Schoon EJ; Deprez PH; Seewald S; Groth S; Giovannini M; Braden B; Berr F; Lemmers A; Hoare J; Bhandari P; van der Post RS; Verhoeven RHA; Siersema PD
    Gastrointest Endosc; 2021 Apr; 93(4):888-898.e1. PubMed ID: 32763242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic evaluation of the esophageal cancer patient after chemoradiotherapy for persistent/recurrent cancer.
    Cosgrove ND; Mullady DK
    Dis Esophagus; 2018 Jul; 31(7):. PubMed ID: 29931309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salvage Endoscopic Submucosal Dissection for Local Recurrence of Superficial Esophageal Squamous Cell Cancer after Photodynamic Therapy.
    Kanamori A; Goda K; Nakamura T; Yamagishi H; Ohwada A; Abe K; Suzuki T; Kondo M; Tanaka T; Yamamiya A; Takimoto Y; Hoshi K; Arisaka T; Sugaya T; Tominaga K; Majima Y; Iijima M; Irisawa A
    Intern Med; 2022 Jul; 61(14):2149-2153. PubMed ID: 34980795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
    Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
    Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.
    Miyawaki Y; Nakajima Y; Kawada K; Okada T; Tokairin Y; Kawano T
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27001629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
    Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
    Tsou YK; Lee CH; Le PH; Chen BH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
    Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
    World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
    Sasaki K; Nomura M; Kato K; Sakanaka K; Ito Y; Kadota T; Machida R; Kataoka T; Minashi K; Tsubosa Y; Kajiwara T; Fukuda H; Takeuchi H; Mizowaki T; Nishimura Y; Kitagawa Y
    Jpn J Clin Oncol; 2024 Jan; 54(1):103-107. PubMed ID: 37801434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minute duodenal metastasis in a patient with thoracic esophageal squamous cell carcinoma successfully treated with chemoradiotherapy.
    Ando K; Fujiya M; Okumura T
    Dig Endosc; 2019 Jan; 31(1):102. PubMed ID: 30218609
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An analysis of factors affecting the accuracy of endoscopic biopsy after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Chao YK; Wen YW; Chang HK; Tseng CK; Liu YH
    Eur J Surg Oncol; 2017 Dec; 43(12):2366-2373. PubMed ID: 29070435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of local complete response with prognosis after salvage photodynamic therapy for esophageal squamous cell carcinoma.
    Amanuma Y; Horimatsu T; Ohashi S; Tamaoki M; Muto M
    Dig Endosc; 2021 Mar; 33(3):355-363. PubMed ID: 32434267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Hatogai K; Yano T; Kojima T; Onozawa M; Daiko H; Nomura S; Yoda Y; Doi T; Kaneko K; Ohtsu A
    Gastrointest Endosc; 2016 Jun; 83(6):1130-1139.e3. PubMed ID: 26608125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Esophageal cancer patients' survival after complete response to definitive chemoradiotherapy: a retrospective analysis.
    Mori K; Sugawara K; Aikou S; Yamashita H; Yamashita K; Ogura M; Chin K; Watanabe M; Matsubara H; Toh Y; Kakeji Y; Seto Y
    Esophagus; 2021 Jul; 18(3):629-637. PubMed ID: 33625649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.
    Xi M; Xu C; Liao Z; Hofstetter WL; Blum Murphy M; Maru DM; Bhutani MS; Lee JH; Weston B; Komaki R; Lin SH
    Radiother Oncol; 2017 Aug; 124(2):318-324. PubMed ID: 28687396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stricture rate after chemoradiotherapy and radiotherapy for oesophageal squamous cell carcinoma: a 20-year experience.
    Hamer PW; Hight SC; Ward IG; Harris DL; Woodham BL; Flint RS
    ANZ J Surg; 2019 Apr; 89(4):367-371. PubMed ID: 30791194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.